Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Modrof

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|August 13, 2003
Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptideBettina Hartlieb, Jens Modrof, Elke Mühlberger, et al.
Emerging Infectious Diseases|October 29, 2009
West Nile virus infection in plasma of blood and plasma donors, United StatesChristina B Planitzer, Jens Modrof, Mei-ying W Yu, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2009
Hepatitis A virus antibodies in immunoglobulin preparationsMaria R Farcet, Christina B Planitzer, Oliver Stein, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 15, 2020
Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspensionJohanna Kindermann, Michael Karbiener, Sandra M Leydold, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 6, 2020
SARS-CoV-2 and the safety margins of cell-based biological medicinal productsJens Modrof, Astrid Kerschbaum, Maria R Farcet, et al.
Transfusion|April 16, 2008
Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentratesAndreas Berting, Jens Modrof, Ulrike Unger, et al.
Biotechnology and Bioengineering|October 19, 2023
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testingMaria R Farcet, Jens Modrof, Gerhard Antoine, et al.
Vaccine|February 25, 2014
Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccineCornelia Lackner, Sandra M Leydold, Jens Modrof, et al.
Transfusion|September 29, 2007
Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulinsJens Modrof, Andreas Berting, Björn Tille, et al.
Transfusion|September 25, 2015
Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processesMaria R Farcet, Cornelia Lackner, Gerhard Antoine, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|August 13, 2003
Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptideBettina Hartlieb, Jens Modrof, Elke Mühlberger, et al.
Emerging Infectious Diseases|October 29, 2009
West Nile virus infection in plasma of blood and plasma donors, United StatesChristina B Planitzer, Jens Modrof, Mei-ying W Yu, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2009
Hepatitis A virus antibodies in immunoglobulin preparationsMaria R Farcet, Christina B Planitzer, Oliver Stein, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 15, 2020
Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspensionJohanna Kindermann, Michael Karbiener, Sandra M Leydold, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 6, 2020
SARS-CoV-2 and the safety margins of cell-based biological medicinal productsJens Modrof, Astrid Kerschbaum, Maria R Farcet, et al.
Transfusion|April 16, 2008
Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentratesAndreas Berting, Jens Modrof, Ulrike Unger, et al.
Biotechnology and Bioengineering|October 19, 2023
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testingMaria R Farcet, Jens Modrof, Gerhard Antoine, et al.
Vaccine|February 25, 2014
Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccineCornelia Lackner, Sandra M Leydold, Jens Modrof, et al.
Transfusion|September 29, 2007
Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulinsJens Modrof, Andreas Berting, Björn Tille, et al.
Transfusion|September 25, 2015
Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processesMaria R Farcet, Cornelia Lackner, Gerhard Antoine, et al.
Pageof 3